Ken Griffin’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $483M | Buy |
3,323,725
+1,390,058
| +72% | +$192M | 0.05% | 255 |
|
|
2026
Q2 | $248M | Sell |
1,933,667
-1,887,560
| -49% | -$221M | 0.03% | 460 |
|
|
2026
Q1 | $460M | Sell |
3,821,227
-3,000,104
| -44% | -$346M | 0.07% | 197 |
|
|
2025
Q4 | $718M | Buy |
6,821,331
+5,853,277
| +605% | +$549M | 0.11% | 121 |
|
|
2025
Q3 | $81.2M | Buy |
+968,054
| New | +$79.7M | 0.01% | 995 |
|
|
2025
Q2 | – | Sell |
-2,048,739
| Closed | -$163M | – | 14120 |
|
|
2025
Q1 | $184M | Sell |
2,048,739
-3,232,971
| -61% | -$302M | 0.03% | 398 |
|
|
2024
Q4 | $525M | Sell |
5,281,710
-1,759,979
| -25% | -$181M | 0.09% | 135 |
|
|
2024
Q3 | $800M | Sell |
7,041,689
-1,200,378
| -15% | -$143M | 0.15% | 74 |
|
|
2024
Q2 | $1.02B | Buy |
8,242,067
+666,847
| +9% | +$85.9M | 0.21% | 59 |
|
|
2024
Q1 | $1,000M | Buy |
7,575,220
+1,257,049
| +20% | +$155M | 0.19% | 61 |
|
|
2023
Q4 | $689M | Sell |
6,318,171
-358,936
| -5% | -$37.3M | 0.14% | 71 |
|
|
2023
Q3 | $687M | Buy |
6,677,107
+4,837,236
| +263% | +$521M | 0.15% | 66 |
|
|
2023
Q2 | $212M | Buy |
1,839,871
+1,068,727
| +139% | +$121M | 0.04% | 303 |
|
|
2023
Q1 | $82M | Sell |
771,144
-1,715,524
| -69% | -$185M | 0.02% | 730 |
|
|
2022
Q4 | $276M | Sell |
2,486,668
-900,548
| -27% | -$92.1M | 0.06% | 226 |
|
|
2022
Q3 | $292M | Buy |
3,387,216
+1,231,726
| +57% | +$110M | 0.07% | 192 |
|
|
2022
Q2 | $197M | Sell |
2,155,490
-1,233,115
| -36% | -$109M | 0.05% | 285 |
|
|
2022
Q1 | $278M | Buy |
3,388,605
+1,171,399
| +53% | +$92.4M | 0.06% | 232 |
|
|
2021
Q4 | $170M | Sell |
2,217,206
-871,326
| -28% | -$69.4M | 0.03% | 412 |
|
|
2021
Q3 | $232M | Buy |
3,088,532
+138,422
| +5% | +$10.5M | 0.05% | 296 |
|
|
2021
Q2 | $229M | Sell |
2,950,110
-1,431,650
| -33% | -$106M | 0.05% | 276 |
|
|
2021
Q1 | $338M | Sell |
4,381,760
-559,774
| -11% | -$43.3M | 0.08% | 152 |
|
|
2020
Q4 | $404M | Buy |
4,941,534
+2,833,384
| +134% | +$227M | 0.11% | 113 |
|
|
2020
Q3 | $175M | Buy |
2,108,150
+776,626
| +58% | +$63.8M | 0.05% | 238 |
|
|
2020
Q2 | $103M | Sell |
1,331,524
-102,236
| -7% | -$8.07M | 0.04% | 391 |
|
|
2020
Q1 | $110M | Buy |
1,433,760
+496,742
| +53% | +$40.9M | 0.05% | 305 |
|
|
2019
Q4 | $85.2M | Sell |
937,018
-1,707,170
| -65% | -$147M | 0.04% | 471 |
|
|
2019
Q3 | $223M | Buy |
2,644,188
+1,950,861
| +281% | +$164M | 0.11% | 131 |
|
|
2019
Q2 | $58.1M | Sell |
693,327
-577,166
| -45% | -$46.3M | 0.03% | 652 |
|
|
2019
Q1 | $106M | Sell |
1,270,493
-563,408
| -31% | -$44.2M | 0.05% | 344 |
|
|
2018
Q4 | $140M | Sell |
1,833,901
-3,331,026
| -64% | -$246M | 0.08% | 219 |
|
|
2018
Q3 | $366M | Buy |
5,164,927
+1,926,113
| +59% | +$129M | 0.16% | 70 |
|
|
2018
Q2 | $197M | Sell |
3,238,814
-2,825,198
| -47% | -$167M | 0.1% | 156 |
|
|
2018
Q1 | $330M | Sell |
6,064,012
-2,364,413
| -28% | -$134M | 0.18% | 60 |
|
|
2017
Q4 | $474M | Buy |
8,428,425
+7,792,358
| +1,225% | +$453M | 0.29% | 36 |
|
|
2017
Q3 | $40.7M | Sell |
636,067
-1,873,786
| -75% | -$119M | 0.03% | 651 |
|
|
2017
Q2 | $161M | Buy |
2,509,853
+2,103,989
| +518% | +$134M | 0.14% | 114 |
|
|
2017
Q1 | $25.8M | Buy |
405,864
+227,070
| +127% | +$14.4M | 0.02% | 800 |
|
|
2016
Q4 | $10.5M | Sell |
178,794
-3,036,917
| -94% | -$186M | 0.01% | 1314 |
|
|
2016
Q3 | $201M | Buy |
+3,215,711
| New | +$197M | 0.2% | 57 |
|
|
2016
Q2 | – | Sell |
-219,984
| Closed | -$12.3M | – | 7351 |
|
|
2016
Q1 | $11.6M | Sell |
219,984
-262,078
| -54% | -$13.5M | 0.01% | 1091 |
|
|
2015
Q4 | $25.5M | Buy |
482,062
+412,734
| +595% | +$21.8M | 0.03% | 709 |
|
|
2015
Q3 | $3.42M | Sell |
69,328
-1,173,696
| -94% | -$65.3M | ﹤0.01% | 2384 |
|
|
2015
Q2 | $70.8M | Buy |
1,243,024
+335,459
| +37% | +$19.7M | 0.06% | 356 |
|
|
2015
Q1 | $52.2M | Sell |
907,565
-199,556
| -18% | -$11.8M | 0.05% | 465 |
|
|
2014
Q4 | $62.9M | Sell |
1,107,121
-987,991
| -47% | -$57.7M | 0.06% | 351 |
|
|
2014
Q3 | $124M | Buy |
2,095,112
+1,737,374
| +486% | +$102M | 0.13% | 134 |
|
|
2014
Q2 | $20.7M | Sell |
357,738
-1,490,786
| -81% | -$85.2M | 0.02% | 797 |
|
|
2014
Q1 | $105M | Buy |
1,848,524
+1,761,020
| +2,013% | +$95.6M | 0.12% | 159 |
|
|
2013
Q4 | $4.38M | Sell |
87,504
-1,975,695
| -96% | -$94.6M | 0.01% | 1792 |
|
|
2013
Q3 | $98.2M | Buy |
2,063,199
+2,052,959
| +20,048% | +$98.2M | 0.15% | 119 |
|
|
2013
Q2 | $476K | Hold |
10,240
| – | – | ﹤0.01% | 3884 |
|
Other funds holding MRK
Ken Griffin's MRK Position: Q3 2026 in Review
Ken Griffin increased its Merck (MRK) stake by 72% in Q3 2026, buying an estimated $192M and bringing the position to 3,323,725 shares worth $483M. The position accounts for 0.05% of the portfolio, ranked #255.
Ken Griffin first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q2 2024. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Ken Griffin held 3,323,725 shares of Merck worth $483M as of Q3 2026.
- Ken Griffin bought 1,390,058 Merck shares in Q3 2026, an estimated $192M.
- Merck made up 0.05% of Ken Griffin's portfolio in Q3 2026, its #255 holding.
- Ken Griffin first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Ken Griffin's Merck position peaked at $1.02B in Q2 2024.
- 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.